|
1.
|
Chow WH, Devesa SS, Warren JL and Fraumeni
JF Jr: Rising incidence of renal cell carcinoma in the United
States. JAMA. 281:1628–1638. 1999.
|
|
2.
|
Marumo K, Kanayama H, Miyao N, Nakazawa H,
Ozono S, Horie S, Nagamori S, Igarashi T, Hasegawa M, Kimura G,
Nakao M, Nakamoto T and Naito S: Prevalence of renal cell
carcinoma: a nation-wide survey in Japan, 2002. Int J Urol.
14:479–482. 2007.
|
|
3.
|
Da Silva JL, Lacombe C, Bruneval P,
Casadevall N, Leporrier M, Camilleri JP, Bariety J, Tambourin P and
Varet B: Tumor cells are the site of erythropoietin synthesis in
human renal cancers associated with polycythemia. Blood.
75:577–582. 1990.
|
|
4.
|
Westenfelder C and Baranowski RL:
Erythropoietin stimulates proliferation of human renal carcinoma
cells. Kidney Int. 58:647–657. 2000.
|
|
5.
|
Muta H, Funakoshi A, Baba T, Uike N,
Wakasugi H, Kozuru M and Jimi A: Gene expression of erythropoietin
in hepatocellular carcinoma. Intern Med. 33:427–431. 1994.
|
|
6.
|
Trimble M, Caro J, Talalla A and Brain M:
Secondary erythrocytosis due to a cerebellular hemangioblastoma:
demonstration of erythropoietin mRNA in the tumor. Blood.
78:599–601. 1991.
|
|
7.
|
Nseyo UO, Williams PD and Murphy GP:
Clinical significance of erythropoietin levels in renal carcinoma.
Urology. 28:301–306. 1986.
|
|
8.
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996.
|
|
9.
|
Linehan WM, Pinto PA, Srinivasan R, Merino
M, Choyke P, Choyke L, Coleman J, Toro J, Glenn G, Vocke C, Zbar B,
Schmidt LS, Bottaro D and Neckers L: Identification of the genes
for kidney cancer: opportunity for disease-specific targeted
therapeutics. Clin Cancer Res. 13:671–679. 2007.
|
|
10.
|
Prowse AH, Webster AR, Richards FM,
Richard S, Olschwang S, Resche F, Affara NA and Maher ER: Somatic
inactivation of the VHL gene in von Hippel-Lindau disease tumours.
Am J Hum Genet. 60:765–771. 1997.
|
|
11.
|
Na X, Wu G, Ryan CK, Schoen SR,
di’Santagnese PA and Messing EM: Overproduction of vascular
endothelial growth factor related to von Hippel-Lindau tumour
suppressor gene mutations and hypoxia-inducible factor 1α
expression in renal cell carcinoma. J Urol. 170:588–592. 2003.
|
|
12.
|
Gong K, Zhang N, Zhang K and Na Y: The
relationship of erythropoietin overexpression with von
Hippel-Lindau tumour suppressor gene mutations between
hypoxia-inducible factor-1α and -2α in sporadic clear cell renal
carcinoma. Int J Mol Med. 26:907–912. 2010.
|
|
13.
|
Alexandrescu DT, McClure R, Farzanmehr H
and Dasanu CA: Secondary erythrocytosis produced by the tyrosine
kinase inhibitors sunitinib and sorafenib. J Clin Oncol.
26:4047–4078. 2008.
|
|
14.
|
Vroling L, van der Veldt AA, de Haas RR,
Haanen JB, Schuurhuis GJ, Kuik DJ, van Cruijsen H, Verheul HM, van
den Eertwegh AJ, Hoekman K, Boven E, van Hinsbergh VW and
Broxterman HJ: Increased numbers of small circulating endothelial
cells in renal cell cancer patients treated with sunitinib.
Angiogenesis. 12:69–79. 2009.
|
|
15.
|
Ebos JM, Lee CR, Christensen JG, Mutsaers
AJ and Kerbel RS: Multiple circulating proangiogenic factors
induced by sunitinib malate tumor-independent and correlate with
antitumor efficacy. Proc Natl Acad Sci USA. 104:17069–17074.
2007.
|
|
16.
|
Yoshida T, Kin S and Kounami T: A case of
erythropoietin-producing renal cell carcinoma proved by
immunohistochemistry. Hinyokika Kiyo. 43:339–342. 1997.(In
Japanese).
|
|
17.
|
Noguchi Y, Goto T, Yufu Y, Uike N,
Hasegawa Y, Fukuda T, Jimi A and Funakoshi A: Gene expression of
erythropoietin in renal cell carcinoma. Intern Med. 38:991–994.
1999.
|
|
18.
|
Okuyama M, Nishihara M, Hashimoto H,
Kaneko S and Yachiku S: A case of erythropoietin–producing renal
cell carcinoma with polycythemia. Hinyokika Kiyo. 48:531–534.
2002.(In Japanese).
|
|
19.
|
Rad FH, Ulusakarya A, Gad S, Sibony M,
Juin F, Richard S, Machover D and Uzan G: Novel somatic mutations
of the VHL gene in an erythropoietin-producing renal carcinoma
associated with secondary polycythemia and elevated circulating
endothelial progenitor cells. Am J Hematol. 83:155–158. 2008.
|
|
20.
|
Sufrin G, Mirand EA, Moore RH, Chu TM and
Murphy GP: Hormones in renal cancer. J Urol. 117:433–438. 1997.
|
|
21.
|
Ljungherg B, Rasmuson T and Grankvist K:
Erythropoietin in renal cell carcinoma: evaluation of its
usefulness as a tumor marker. Eur Urol. 21:160–163. 1992.
|
|
22.
|
Michael A, Politi E, Havranek E,
Corbishley C, Karapanagiotou L, Anderson C, Relph K, Syrigos KN and
Pandha H: Prognostic significance of erythropoietin expression in
human renal cell carcinoma. BJU Int. 100:291–294. 2007.
|
|
23.
|
Westenfelder C, Biddle DL and Baranowski
RL: Human, rat, and mouse kidney cells express functional
erythropoietin receptors. Kidney Int. 55:808–820. 1999.
|
|
24.
|
Yomogi H, Odajima K, Nakamura H, et al: A
case of erythropoietin-producing renal cell carcinoma. Rinsho
Hinyokika. 48:139–141. 1994.
|
|
25.
|
Teishima T, Sumi H, Ikemoto H, Himeno Y
and Ishino T: A case of erythropoietin-producing renal cell
carcinoma. Jpn J Urol Surg. 9:1181–1183. 1996.
|
|
26.
|
Sato T, Hukui J, Okamoto S, et al: A case
of renal cell carcinoma with polycythemia. Jpn J Urol Surg.
11:85–87. 1998.
|
|
27.
|
Morita S, Watanabe K, Sakamoto H, et al: A
case of erythropoietin-producing renal cell carcinoma. Rinsho
Hinyokika. 55:651–653. 2001.
|
|
28.
|
Hirose Y, Ando R, Nakane A, Akita H and
Okamura T: A case of erythropoietin-producing renal cell carcinoma.
Jpn J Urol Surg. 24:187–190. 2011.
|
